Blog

Democracy

Wisconsin Republicans Are Reminding Us Once Again That They…

The Wisconsin GOP is at it again. With the party’s stranglehold on the State Supreme Court in peril following a judicial election last spring, Republicans are now seeking to impeach the new judge before the court can throw out the state’s rigged election maps. Few elections in recent US history have arguably been as consequential as the

Capitalism

Poverty increased in 2022 as wages fell and inflation…

A measure of poverty tracked by the Census Bureau rose in 2022, as COVID era benefits expired and average income fell, according to a Tuesday report. Why it matters: Child poverty saw a sharp increase in 2022 following a record low the year prior. Driving the news: While the official poverty rate (considered an outdated measure) didn’t see a significant change from 2021 to

Labor

The National Labor Relations Board Just Made It Easier…

An NLRB decision delivered late last month substantially lowers the legal hurdles to union recognition. But using that opening will require unions to build strong cultures of shop-floor solidarity in the face of employer intimidation. On August 25, the National Labor Relations Board (NLRB) handed down a decision in Cemex Construction Materials Pacific, LLC and International

Conservatives

Ohio Republicans accused of trying to mislead voters with…

Last week, the Ohio ballot board – led by the Republican secretary of state, Frank LaRose – approved the wording of Issue 1, a November ballot measure that will ask voters if the state constitution should guarantee a right to abortion, contraception, fertility treatment and miscarriage care. The new lawsuit accuses the ballot board’s Republican majority of

Capitalism

Big Pharma Is Threatening to Withhold Medicine in Protest…

The 2022 Inflation Reduction Act introduced modest drug pricing restrictions. In response, big pharma companies — which have seen record profits — are threatening to slow the rollout of a lifesaving drug. A Swiss pharmaceutical company announced this month that it could slow-walk bringing a potentially lifesaving drug to market — in order to reduce